Skip to main navigation Skip to search Skip to main content

Group G streptococcal bacteremia in Jerusalem

  • Ronit Cohen-Poradosu
  • , Joseph Jaffe
  • , David Lavi
  • , Sigal Grisariu-Greenzaid
  • , Ran Nir-Paz
  • , Lea Valinsky
  • , Mary Dan-Goor
  • , Colin Block
  • , Bernard Beall
  • , Allon E. Moses*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Abstract

Group G Streptococcus (GGS) can cause severe infections, including bacteremia. These organisms often express a surface protein homologous to the Streptococcus pyogenes M protein. We retrospectively studied the characteristics of patients from the Hadassah Medical Center with GGS bacteremia from 1989 to 2000. Ninety-four cases of GGS bacteremia were identified in 84 patients. The median age was 62 years, 54% were males, and 92% had underlying diseases (35% had a malignancy, and 35% had diabetes mellitus). The most frequent source for bacteremia was cellulitis (61%). emm typing of 56 available isolates disclosed 13 different types, including 2 novel types. Six patients had recurrent bacteremia with two to four bacteremic episodes, five had chronic lymphatic disorders, and two had emm type sfG840.0 in every episode. Recurrent bacteremia has not been described for invasive group A Streptococcus. We describe an entity of recurrent GGS bacteremia, which is associated with lymphatic disorders and possibly with emm sfG840.0.

Original languageEnglish
Pages (from-to)1455-1460
Number of pages6
JournalEmerging Infectious Diseases
Volume10
Issue number8
DOIs
StatePublished - Aug 2004
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Group G streptococcal bacteremia in Jerusalem'. Together they form a unique fingerprint.

Cite this